Metsera Inc MTSR

$70.50 -0.25 (-0.35%)

Valuation

Market cap
7,423,156,000
Revenue TTM
$0
Net income TTM
$-209,130,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
27,908,900
Avg volume
3,697,740
Day's range
$70.13 – $70.78
Shares out
105,293,000
Stochastic %K
43%
Beta
—
Analysts
Strong Sell
Price target
$55.75

Price

Company profile

Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity, as well as MET-815i to reduce weight or preven...

Show more

Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity, as well as MET-815i to reduce weight or prevents weight gain. The company was incorporated in 2022 and is based in New York, New York. As of November 13, 2025, Metsera, Inc. operates as a subsidiary of Pfizer Inc.

Industry
Biotechnology
Sector
Healthcare
Phone
212 784 6595
Website
https://metsera.com
Address
3 World Trade Center, 175 Greenwich Street, New York, United States

Latest news

Stocktwits

Freakyguy666 Sep 26, 8:57 PM
$MTSR $PFE $VKTX back then BL wanted $15B so you might wanna save some of your blame for yer boy Brian Lian
1 replies
GPTInsights Sep 26, 8:00 PM
$VKTX $PFE Bourla is a moron for wasting 10 billion on $MTSR . I know they are focused on monthly but the low efficacy almost elminates the point. Could have gotten viking and had something similar to retatrutide with oral and maintenance optionality.
0 replies
JackedNicholson Sep 24, 10:17 PM
$ALT $NVO just scoop it for $10B for God’s sake! You were about to spend that amount for $MTSR and half of their program slashed by $PFE… $10B and you have Pemvidutide franchise…
2 replies
himsssss Sep 2, 8:12 PM
$VKTX The bulls were right, I shouldnt have held $MTSR and x4 my money under a year, should of held viking and keep bleeding out money.
3 replies
Pika_Capital Aug 18, 4:31 AM
$MTSR $ORKA $IMVT This is one of the wildest move ive ever made in bios. Proceeds from mtsr (buyout +100% gain) compounded +600% in orka and +200% in imvt. Trying to keep emotions in check though. It's very easy to lose everything in this sector.
2 replies
inv1ncible Aug 5, 1:20 PM
$PFE spent $10 Billion for $MTSR for nothing 🙄. Stupid Albert
0 replies
Insayn Jul 16, 7:01 PM
$ATAI reminds me of the $MTSR setup: Pfizer had already signed a merger agreement with Metsera, yet 38 days later Novo Nordisk submitted a superior proposal and triggered a bidding war. Lilly’s $6.75 cash + up to $2.50 CVR deal is signed, but ATAI can still consider an unsolicited superior offer before shareholder approval. No guarantee — but history shows a signed biotech deal is not always the final deal. 👀💎🙌 $LLY #Biotech #MergersAndAcquisitions
1 replies
himsssss May 15, 7:45 PM
$VKTX holding onto vs $MTSR in 2025. In 1 year you could of got a 207% gain but settled for 7%.
0 replies